A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR

J T Grayston1, L A Campbell, C C Kuo

  • 1Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle 98195.

Insights

Chlamydia pneumoniae strain TWAR causes pneumonia and respiratory infections, affecting nearly everyone globally. While often mild, severe cases and transmission necessitate prompt diagnosis and treatment.

Area of Science:

  • Infectious Diseases
  • Respiratory Medicine
  • Microbiology

Background:

  • Chlamydia pneumoniae strain TWAR is a newly identified species of Chlamydia.
  • It is a significant cause of pneumonia and acute respiratory tract infections.

Purpose of the Study:

  • To summarize the epidemiology, clinical presentation, and management of Chlamydia pneumoniae strain TWAR infections.
  • To highlight its global prevalence and impact on respiratory health.

Main Methods:

  • Review of existing literature and epidemiological data on TWAR infections.
  • Analysis of population prevalence antibody studies.

Main Results:

  • TWAR strain accounts for approximately 10% of pneumonia cases.
  • Infections are widespread globally, with most individuals experiencing reinfection throughout their lifetime.
  • Common in all age groups except children under 5 in temperate regions.

Conclusions:

  • Chlamydia pneumoniae strain TWAR is a major global cause of respiratory illness.
  • Effective treatment involves tetracycline or erythromycin.
  • Further research into diagnosis and prevention is warranted.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...